B

Beta Bionics

92 employees

Beta Bionics is a biotechnology company that develops an integrated bionic pancreas system called the iLet.

Basic info

Industry

biotechnology research

Sectors

the iLet Bionic Pancreas
Medical Device
Biotechnology
Diabetes

Date founded

2015

Funding rounds raised

Total raised

$100M

from 30 investors over 30 rounds

B

Beta Bionics raised $100M on August 30, 2023

Investors: Sands Capital Management, Farallon Capital Management, Pura Vida Investments, Perceptive Advisors, Marshall Wace, RTW Investments, LP, Soleus Capital Management, L.P., Eventide Asset Management, LifeSci Venture Partners and Omega Funds

B

Beta Bionics raised $57M on February 17, 2022

Investors: Soleus Capital Management, L.P., Pura Vida Investments, Novo Nordisk Ltd, LifeSci Venture Partners, Eventide Asset Management, RTW Investments, LP, Farallon Capital Management and Perceptive Advisors

B

Beta Bionics raised $63M on July 1, 2019

Investors: Soleus Capital Management, L.P., Eventide Asset Management, RTW Investments, LP, Perceptive Advisors and Farallon Capital Management

B

Beta Bionics raised $63M on January 8, 2019

Investors: Zealand Pharma, RTW Investments, LP, Eventide Asset Management, LifeSci Venture Partners and Dexcom

B

Beta Bionics raised $2M on October 2, 2018

Investors: NIDDK, NIH

B

Beta Bionics raised $5M on December 31, 2015

Investors: Novo Nordisk Ltd

FAQ